SpaceX Successfully Launches Starship on Second Attempt in Key Test Flight OIG Report Criticizes USP Canaan Prison Conditions Systemic Issues May Drive Policy Reform Brainbees Solutions Q4 Results Firstcry Parent Narrows Loss to Rs 30 Crore on 12 Revenue Growth Canadian Natural Resources CNQ Positioned as Key Natural Gas Player for Energy Transition Indian Benchmarks Edge Lower for Second Consecutive Session Nifty Faces Key Support at 23800 Marvell Technology Faces High Expectations as AI Demand Drives Anticipated Strong Quarter Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline ACMR Q1 2026 Earnings EPS Surges Past Estimates as Operational Efficiency Drives Profitability SFIX Q1 2026 Earnings NarrowerThanExpected Loss Signals Cost Control Progress XYF Q1 2020 Earnings Significant EPS Miss Amid Pandemic Challenges United Parks Resorts PRKS Q1 2026 Earnings WiderThanExpected Loss Fails to Dampen Investor Sentiment WILC Q4 2025 Earnings Solid EPS Despite Absence of Revenue Guidance Stock Dips 336 Midland States Bancorp MSBI Edges Lower Amid Quiet Trading Insight Digital Partners II DYOR Holds Near Support Amid Low Volatility Prenetics Global PRE Surges 678 Key Levels and Technical Outlook DigitalBridge Group DBRG Holds Steady Near Support as Volume Signals Caution Highwoods Properties HIW Edges Higher as Real Estate Sector Shows Signs of Stabilization Investing in the Era of Scarcity Market Blindness to Government Hoarding Trends WTTR Q1 2026 Earnings EPS Surges 106 Above Estimates as Water Solutions Sector Strengthens Irans Potential Tariffs on Hormuz Internet Cables Could Raise Europes Connectivity Costs Pluri Inc PLUR Q1 2026 Earnings WiderthanExpected Loss Sends Shares Lower YUM Q1 2026 Earnings Earnings Beat Driven by Strong Margins and Digital Growth CIG Q1 2026 Earnings EPS Beats Estimates But Stock Slips 26 IndoStar Capital Reports 130 Crore Annual Profit but Q4 Loss Widens on Security Receipt Provisions WST Q1 2026 Earnings EPS Surges Past Estimates by 2578 Royalty Pharma RPRX Holds Steady Near Support Potential for Breakout Above Resistance